Toxic proteins application in cancer therapy
- PMID: 33895972
- DOI: 10.1007/s11033-021-06363-4
Toxic proteins application in cancer therapy
Abstract
Ribosome inactivating proteins (RIPs) as family of anti-cancer drugs recently received much attention due to their interesting anti-cancer mechanism. In spite of small drugs, RIPs use the large-size effect (LSE) to prevent the efflux process governed by drug resistance transporters (DRTs) which prevents inside of the cells against drug transfection. There are many clinical translation obstacles that severely restrict their applications especially their delivery approach to the tumor cells. As the main goal of this review, we will focus on trichosanthin (TCS) and gelonin (Gel) and other types, especially scorpion venom-derived RIPs to clarify that they are struggling with what types of bio-barriers and these challenges could be solved in cancer therapy science. Then, we will try to highlight recent state-of-the-arts in delivery of RIPs for cancer therapy.
Keywords: Cancer; Cytotoxicity; Drug delivery; Proteins; Scorpion venom; Tumor.
Similar articles
-
Recent progress in medicinal investigations on trichosanthin and other ribosome inactivating proteins from the plant genus Trichosanthes.Curr Med Chem. 2011;18(28):4410-7. doi: 10.2174/092986711797200499. Curr Med Chem. 2011. PMID: 21861819 Review.
-
Genetic engineering and characterisation of chlorotoxin-fused gelonin for enhanced glioblastoma therapy.J Drug Target. 2019 Nov;27(9):950-958. doi: 10.1080/1061186X.2018.1516221. Epub 2018 Sep 11. J Drug Target. 2019. PMID: 30156929
-
Advances on Tumor-Targeting Delivery of Cytotoxic Proteins.ACS Pharmacol Transl Sci. 2019 Dec 30;3(1):107-118. doi: 10.1021/acsptsci.9b00087. eCollection 2020 Feb 14. ACS Pharmacol Transl Sci. 2019. PMID: 32259092 Free PMC article. Review.
-
Studies on the anti-mitogenic, anti-phage and hypotensive effects of several ribosome inactivating proteins.Comp Biochem Physiol C Toxicol Pharmacol. 2001 Mar;128(3):359-66. doi: 10.1016/s1532-0456(00)00208-8. Comp Biochem Physiol C Toxicol Pharmacol. 2001. PMID: 11255109
-
Relationship between trichosanthin cytotoxicity and its intracellular concentration.Toxicology. 2002 Aug 15;177(2-3):245-51. doi: 10.1016/s0300-483x(02)00226-3. Toxicology. 2002. PMID: 12135627
Cited by
-
Ribosomes and Ribosomal Proteins Promote Plasticity and Stemness Induction in Glioma Cells via Reprogramming.Cells. 2022 Jul 7;11(14):2142. doi: 10.3390/cells11142142. Cells. 2022. PMID: 35883585 Free PMC article. Review.
-
Exploring two tumor treatment strategies: effectiveness of ribosome inactivating proteins and mesenchymal stem cells/MSC derived extracellular vesicles in cancer treatment.Front Oncol. 2025 May 13;15:1533065. doi: 10.3389/fonc.2025.1533065. eCollection 2025. Front Oncol. 2025. PMID: 40444089 Free PMC article. Review.
-
MAPK Cascade Signaling Is Involved in α-MMC Induced Growth Inhibition of Multiple Myeloma MM.1S Cells via G2 Arrest and Mitochondrial-Pathway-Dependent Apoptosis In Vitro.Pharmaceuticals (Basel). 2023 Jan 13;16(1):124. doi: 10.3390/ph16010124. Pharmaceuticals (Basel). 2023. PMID: 36678620 Free PMC article.
-
Ribosomal proteins induce stem cell-like characteristics in glioma cells as an "extra-ribosomal function".Brain Tumor Pathol. 2022 Apr;39(2):51-56. doi: 10.1007/s10014-022-00434-5. Epub 2022 May 5. Brain Tumor Pathol. 2022. PMID: 35508789 Review.
-
Targeting hexokinase 2 to enhance anticancer efficacy of trichosanthin in HeLa and SCC25 cell models.ADMET DMPK. 2024 Sep 22;12(6):821-841. doi: 10.5599/admet.2455. eCollection 2024. ADMET DMPK. 2024. PMID: 39713255 Free PMC article.
References
-
- Shapira A, Benhar I (2010) Toxin-based therapeutic approaches. Toxins 2(11):2519–2583. https://doi.org/10.3390/toxins2112519 - DOI - PubMed - PMC
-
- Maraganore JM, Joseph M, Bailey MC (1987) Purification and characterization of trichosanthin. Homology to the ricin A chain and implications as to mechanism of abortifacient activity. J Biol Chem 262(24):11628–11633. https://doi.org/10.1016/S0021-9258(18)60855-5 - DOI - PubMed
-
- Shi WW, Wong KB, Shaw PC (2018) Structural and functional investigation and pharmacological mechanism of trichosanthin, a type 1 ribosome-inactivating protein. Toxins 10(8):335. https://doi.org/10.3390/toxins10080335 - DOI - PMC
-
- Zhang C, Gong Y, Ma H, An C, Chen ZL (2001) Reactive oxygen species involved in trichosanthin-induced apoptosis of human choriocarcinoma cells. Biochem J 355(3):653–661. https://doi.org/10.1042/bj3550653 - DOI - PubMed - PMC
-
- Li M, Li X, Li JC (2010) Possible mechanisms of trichosanthin-induced apoptosis of tumor cells. Anat Rec 293(6):986–992. https://doi.org/10.1002/ar.21142 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials